SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-037526
Filing Date
2020-02-14
Accepted
2020-02-14 13:09:06
Documents
3
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND V GP MANAGER, LTD.OMEGA FUND V GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d766249dsc13ga.htm SC 13G/A 135472
2 EX-99.1 d766249dex991.htm EX-99.1 7370
3 EX-99.2 d766249dex992.htm EX-99.2 10434
  Complete submission text file 0001193125-20-037526.txt   155066
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Subject) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88806 | Film No.: 20617237
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund V, L.P. (Filed by) CIK: 0001641354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A